Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Muscle Relaxant Recalled
12/10/2020
The FDA has issued a recall for a prescription muscle relaxant indicated for the management of spasticity.
The FDA has issued a recall for a prescription muscle relaxant indicated for the management of spasticity.
The FDA has issued a recall for...
12/10/2020
Pharmacy Learning Network
News
Blood Pressure Medicine Recalled
12/03/2020
A nationwide recall is active for a prescription medication used to treat high blood pressure.
A nationwide recall is active for a prescription medication used to treat high blood pressure.
A nationwide recall is active...
12/03/2020
Pharmacy Learning Network
News
Chemotherapy Medication Recalled
12/03/2020
Nearly 17,000 single-dose vials of doxorubicin hydrochloride injection are being recalled by Fresenius Kabi USA after testing revealed trace amounts of octreotide.
Nearly 17,000 single-dose vials of doxorubicin hydrochloride injection are being recalled by Fresenius Kabi USA after testing revealed trace amounts of octreotide.
Nearly 17,000 single-dose vials...
12/03/2020
Pharmacy Learning Network

Advertisement

News
Antidepressant Recalled
12/03/2020
The FDA is recalling a prescription antidepressant used to treat people with obsessive-compulsive disorder.
The FDA is recalling a prescription antidepressant used to treat people with obsessive-compulsive disorder.
The FDA is recalling a...
12/03/2020
Pharmacy Learning Network
News
Anticonvulsant Recalled
12/03/2020
A Class II recall is active for a prescription anticonvulsant used to treat adults and children with epilepsy.
A Class II recall is active for a prescription anticonvulsant used to treat adults and children with epilepsy.
A Class II recall is active for...
12/03/2020
Pharmacy Learning Network
News
Feds Look to Pharmacists to Boost Childhood Immunization Rates
12/03/2020
Fears over COVID-19 have contributed to a slump in inoculations among children. Now the federal government is looking to pharmacists for help, but many of them do not participate in a program that offers free shots to half the kids in the US.
Fears over COVID-19 have contributed to a slump in inoculations among children. Now the federal government is looking to pharmacists for help, but many of them do not participate in a program that offers free shots to half the kids in the US.
Fears over COVID-19 have...
12/03/2020
Pharmacy Learning Network

Advertisement

News
How COVID-19 Highlights the Uncertainty of Medical Testing
12/02/2020
Widespread COVID testing has revealed uncomfortable truths about medical tests: a test result is rarely a definitive answer, but instead a single clue. A result may be falsely positive or negative, or it may show an abnormality that doesn’t...
Widespread COVID testing has revealed uncomfortable truths about medical tests: a test result is rarely a definitive answer, but instead a single clue. A result may be falsely positive or negative, or it may show an abnormality that doesn’t...
Widespread COVID testing has...
12/02/2020
Pharmacy Learning Network
News
Antipsychotic Recalled
11/25/2020
Apotex Corp. is recalling two lots of 15-mg aripiprazole tablets because they tested out of specification for dissolution.
Apotex Corp. is recalling two lots of 15-mg aripiprazole tablets because they tested out of specification for dissolution.
Apotex Corp. is recalling two...
11/25/2020
Pharmacy Learning Network
News
Diabetes Drug Recalled
11/25/2020
A Class II recall is active for a prescription medication used to help control blood sugar levels in people with type 2 diabetes due to the detection of an NDMA impurity that tested above an acceptable level.
A Class II recall is active for a prescription medication used to help control blood sugar levels in people with type 2 diabetes due to the detection of an NDMA impurity that tested above an acceptable level.
A Class II recall is active for...
11/25/2020
Pharmacy Learning Network

Advertisement

News
Pain Tablets Recalled
11/25/2020
The discovery of a losartan tablet in a bottle of hydrocodone bitartrate and acetaminophen tablets has prompted Ascent Pharmaceuticals Inc. to recall the entire lot.
The discovery of a losartan tablet in a bottle of hydrocodone bitartrate and acetaminophen tablets has prompted Ascent Pharmaceuticals Inc. to recall the entire lot.
The discovery of a losartan...
11/25/2020
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use